Senaparib
Senaparib (IMP4297) is an orally bioavailable, highly selective PARP1/2 inhibitor demonstrating potent antitumor activity. It is a research tool for investigating DNA damage response pathways in cancers such as ovarian and breast, with studies showing efficacy in both cellular and animal models.
Product Specifications
CAS Number
1401682-78-7
Product Name Alternative
Cancer, breast, inhibit, IMP 4297, IMP4297, IMP-4297, pancreatic, poly ADP ribose polymerase, PARP1, PARP, PCa, PARP2, Inhibitor, Senaparib
Field of Research
Epigenetics & Chromatin, Molecular Biology
Purity
99.41% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:3.3 mg/mL (6.9 mM) ; DMSO:75 mg/mL (156.76 mM)
Smiles
Fc1ccc (Cn2c3cccc (F) c3c (=O) [nH]c2=O) cc1C (=O) N1CCN (CC1) c1ncccn1
Molecular Formula
C24H20F2N6O3
Molecular Weight
478.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15227836 1 Vial
Lentiviral mouse Nprl2 shRNA (UAS) - Lentiviral mouse Nprl2 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 
RR210930L4V 200 µL
Kctd21 (NM_001109151) Rat Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 